Evidence map›Paper›PMID 28392688›Full record

ArticleInternational journal of nanomedicine2017

Evaluation of zinc-doped mesoporous hydroxyapatite microspheres for the construction of a novel biomimetic scaffold optimized for bone augmentation.

Weilin Yu, Tuan-Wei Sun, Chao Qi, Zhenyu Ding, Huakun Zhao, Shichang Zhao, Zhongmin Shi, Ying-Jie Zhu, Daoyun Chen, Yaohua He

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Bioactive materials · 2021
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Zinc as a Therapeutic Agent in Bone Regeneration.Materials (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Weilin YuDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Tuan-Wei SunState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai; University of Chinese Academy of Sciences, Beijing.
Chao QiState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai; University of Chinese Academy of Sciences, Beijing.
Zhenyu DingDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Huakun ZhaoDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Shichang ZhaoDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Zhongmin ShiDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Ying-Jie ZhuState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai; University of Chinese Academy of Sciences, Beijing.
Daoyun ChenDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
Yaohua HeDepartment of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital; School of Biomedical Engineering, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Funding

The PERMSS Project-Promoting Education and Research on Mood, Stress, & SubstancesK23AA020316 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI ALVANZO, ANIKA A.H. · 2012 to 2016
$910k
NIAAA NIH HHS K23 AA020316
6 · The paper itself

Abstract

Biomaterials with high osteogenic activity are desirable for sufficient healing of bone defects resulting from trauma, tumor, infection, and congenital abnormalities. Synthetic materials mimicking the structure and composition of human trabecular bone are of considerable potential in bone augmentation. In the present study, a zinc (Zn)-doped mesoporous hydroxyapatite microspheres (Zn-MHMs)/collagen scaffold (Zn-MHMs/Coll) was developed through a lyophilization fabrication process and designed to mimic the trabecular bone. The Zn-MHMs were synthesized through a microwave-hydrothermal method by using creatine phosphate as an organic phosphorus source. Zn-MHMs that consist of hydroxyapatite nanosheets showed relatively uniform spherical morphology, mesoporous hollow structure, high specific surface area, and homogeneous Zn distribution. They were additionally investigated as a drug nanocarrier, which was efficient in drug delivery and presented a pH-responsive drug release behavior. Furthermore, they were incorporated into the collagen matrix to construct a biomimetic scaffold optimized for bone tissue regeneration. The Zn-MHMs/Coll scaffolds showed an interconnected pore structure in the range of 100-300 μm and a sustained release of Zn ions. More importantly, the Zn-MHMs/Coll scaffolds could enhance the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Finally, the bone defect repair results of critical-sized femoral condyle defect rat model demonstrated that the Zn-MHMs/Coll scaffolds could enhance bone regeneration compared with the Coll or MHMs/Coll scaffolds. The results suggest that the biomimetic Zn-MHMs/Coll scaffolds may be of enormous potential in bone repair and regeneration.

Indexed as

Bone RegenerationAnimalsBiocompatible MaterialsBiomimetic MaterialsBiomimeticsBone and BonesCell DifferentiationCollagenDurapatiteMaleMesenchymal Stem CellsMicrospheresOsteogenesisRats, Sprague-DawleyTissue ScaffoldsZincBiocompatible MaterialsCollagenDurapatiteZincbiomimicrybone regenerationdrug deliverymesoporous hydroxyapatite microspheresscaffoldzinc

Identifiers

PMID28392688
PMCPMC5373825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.